Fundraising FoxMedvest Capital
Venture capitalPalm Beach Gardens · Seed–Series A · 3 people tracked
Find your way into Medvest Capital
Sign up to see every warm intro you have to Medvest Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Medvest Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Medvest Capital is a mission-driven venture firm focused on early-stage medical device companies. Its investment approach centers on three interrelated principles: improving patient outcomes, decreasing delivery costs, and minimizing provider risk. Beyond capital, the firm works closely with portfolio company management to validate market feasibility, fast-track product development, and establish the business processes needed for sustainable growth. Target investments range from $1 million to $3 million.
Source: firm website, verified Aug 3, 2026.
Team · 3 people
from the firm's website & public directories
What they invest in
from 4 of 7 portfolio companiesMedical Devices ×3Biotech ×2Hardware ×2Healthtech ×2Deep Tech ×1Digital Health ×1Mental Health ×1
HQs:United States×3
Investments · 7 tracked
founders shown can be your intro path
BrightSpec develops molecular rotational resonance (MRR) spectroscopy instruments and software that identify and quantify gas-phase molecules from complex mixtures without front-end separation.
BiotechDeep TechHardwareWaltham, US
Rick Gordon(CEO)inWalter Colsman(Executive Officer, Director)JAFFRAY WOODRIFF(Director)ROBERT LLOYD(Executive Officer, Director)THOMAS JONES(Director)DAVID MCDANIEL(Executive Officer, Director)
Co-investorsArboretum VenturesGenoa Ventures
Freespira develops an FDA-indicated medical device combined with clinical support for treating PTSD and panic disorder symptoms at home over 28 days.
Digital HealthHealthtechMedical DevicesMental Health
Co-investorsAphelion CapitalLightspeed Venture Partners
Mercator MedSystems develops catheter-based Micro-Infusion technologies, including the Bullfrog Micro-Infusion Device, for the local delivery of pharmacologic and biologic agents to the peripheral vasculature.
BiotechHealthtechMedical DevicesSan Leandro, US
Kirk P. Seward(Co-founder, President and CEO)inTrent Reutiman(Executive Officer, Director)Stephen Baker(Executive Officer)Charles Crocker(Director)Doug Wall(Director)
BoardNed Scheetz(Director)in
Co-investorsAphelion Capital
Providence Medical Technology develops surgical instrumentation and implants for posterior cervical fusion procedures, targeting the cervical spine market for high-risk patients.
HardwareMedical Devices
Co-investorsAphelion Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Joint Purification SystemsProvidence Medical TechnologySafeWire
Frequently asked questions
- How many investments has Medvest Capital made?
- Medvest Capital has 7 tracked investments.
- What stage does Medvest Capital invest at?
- Medvest Capital invests at the Seed, Series A stages.
- What is Medvest Capital's typical check size?
- Medvest Capital typically writes checks of $1M – $3M.
- What sectors does Medvest Capital focus on?
- Medvest Capital focuses on Healthtech, Medical Devices.
- Where is Medvest Capital located?
- Medvest Capital is headquartered in Palm Beach Gardens, US.
- Who does Medvest Capital co-invest with?
- Medvest Capital most often shares deals with Aphelion Capital, Arboretum Ventures, Genoa Ventures, among 4 tracked co-investors.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Blackbird is a venture capital firm that backs founders from the earliest stages, with a focus on ambitious technology startups across Australia and New Zealand.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.